Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Loose anagen hair syndrome, often affecting young girls, can be diagnosed with a hair-pull test and usually gets better on its own, but severe cases may need treatment.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

A genetic marker linked to a type of hair loss was found in most patients studied.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

BeauTop improves hair growth in androgenetic alopecia patients.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Monofilament Threads significantly improve hair growth in women with pattern hair loss and are safe.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Both fat-derived stem cells and platelet-rich plasma are effective and safe for hair loss, but stem cells give better results with more side effects.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

FAGA shows varied hair thickness, while TE has more empty follicles.

FFA has higher long-term remission rates than LPP.

Platelet-rich plasma helps improve skin and hair conditions.

Eclipta prostrata is a medicinal herb with potential health benefits for various conditions and could be used in modern medicine.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Targeting IL-17 could help treat pattern hair loss.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.